1. Home
  2. ARCT vs ECX Comparison

ARCT vs ECX Comparison

Compare ARCT & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • ECX
  • Stock Information
  • Founded
  • ARCT 2013
  • ECX 2017
  • Country
  • ARCT United States
  • ECX China
  • Employees
  • ARCT N/A
  • ECX N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • ECX EDP Services
  • Sector
  • ARCT Health Care
  • ECX Technology
  • Exchange
  • ARCT Nasdaq
  • ECX Nasdaq
  • Market Cap
  • ARCT 487.0M
  • ECX 584.9M
  • IPO Year
  • ARCT N/A
  • ECX N/A
  • Fundamental
  • Price
  • ARCT $17.12
  • ECX $1.82
  • Analyst Decision
  • ARCT Strong Buy
  • ECX
  • Analyst Count
  • ARCT 7
  • ECX 0
  • Target Price
  • ARCT $65.00
  • ECX N/A
  • AVG Volume (30 Days)
  • ARCT 356.8K
  • ECX 1.5M
  • Earning Date
  • ARCT 03-06-2025
  • ECX 02-26-2025
  • Dividend Yield
  • ARCT N/A
  • ECX N/A
  • EPS Growth
  • ARCT N/A
  • ECX N/A
  • EPS
  • ARCT N/A
  • ECX N/A
  • Revenue
  • ARCT $160,399,000.00
  • ECX $778,608,168.00
  • Revenue This Year
  • ARCT $7.33
  • ECX $20.12
  • Revenue Next Year
  • ARCT $4.71
  • ECX $32.70
  • P/E Ratio
  • ARCT N/A
  • ECX N/A
  • Revenue Growth
  • ARCT N/A
  • ECX 25.45
  • 52 Week Low
  • ARCT $14.30
  • ECX $0.96
  • 52 Week High
  • ARCT $45.00
  • ECX $3.09
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 48.75
  • ECX 43.77
  • Support Level
  • ARCT $15.82
  • ECX $1.73
  • Resistance Level
  • ARCT $17.93
  • ECX $1.97
  • Average True Range (ATR)
  • ARCT 1.51
  • ECX 0.13
  • MACD
  • ARCT -0.04
  • ECX -0.03
  • Stochastic Oscillator
  • ARCT 23.90
  • ECX 17.31

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: